Skip to main content
TipRanks
Go Ultimate75% OFF

Leland Gershell Insider Profile

4 Followers

Leland Gershell, Chief Financial Officer at Capricor Therapeutics, holds ― shares in Capricor Therapeutics (Ticker: CAPR), holds 19.26K shares in Tonix Pharma (Ticker: TNXP). Most recently, Leland Gershell Bought ― shares of Capricor Therapeutics on Mar 18, 2016 for an estimated value of $5.04K.

Leland Gershell's Trading History

CAPR
Capricor Therapeutics
Mar 18, 2016Chief Financial OfficerInformative Buy5.04K―
TNXP
Tonix Pharma
Sep 29, 2015CFOInformative Buy2.33K$57.97K

You May Also Like

Leland Gershell insider profile FAQ

What is the percentage of profitable transactions made by Leland Gershell?
The percentage of profitable transactions made by Leland Gershell is 40%.
What is the average return per transaction made by Leland Gershell?
The average return per transaction made by Leland Gershell is -32.90%.
What stocks does Leland Gershell hold?
Leland Gershell holds: CAPR, TNXP stocks.
What was Leland Gershell’s latest transaction?
Leland Gershell’s latest transaction was an Informative Buy of $5.04K.
What was Leland Gershell's most profitable transaction?
Leland Gershell’s most profitable transaction was an Informative Buy of CAPR stock on March 18, 2016. The return on the trade was 26.90%.
What is Leland Gershell's role in Capricor Therapeutics?
Leland Gershell's role in Capricor Therapeutics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.